IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Pronova Signs Intermediates Deal

10:52 AM MDT | September 8, 2008 | Chemical Week Editorial Staff

Pronova Biopharma (Lysaker, Norway) says it has entered into an agreement with an undisclosed third-party manufacturer for the supply of pharmaceutical intermediates, which will enable Pronova to make higher volumes of active pharma ingredients (API). The additional supply of cGMP-manufactured intermediates will raise Pronova’s total annual API production volume to 1,400 m.t.-1,500 m.t., the company says. “The sourcing of high-quality intermediates will further optimize our manufacturing processes,” says Tomas Settevik, CEO of Pronova...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa